A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.

NCT00349635 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Metformin and Metformin + Fenofibrate

Sponsor

Solvay Pharmaceuticals